Roch Holding AG is a global healthcare company that operates in multiple regions, including Europe, North America, Latin America, Asia, Africa, Australia, and Oceania.
The company's pharmaceutical division focuses on developing and commercializing medicines in various therapeutic areas, such as anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Additionally, Roche is actively investing in research and development to expand its product portfolio across multiple disease areas.
Roche's diagnostics business is a leading provider of in vitro tests, which enable healthcare professionals to diagnose and monitor various diseases, including cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other conditions. The company also offers a range of diagnostic instruments and digital health solutions, which support healthcare professionals in making informed decisions and improving patient outcomes.
With a rich history dating back to 1896, Roche Holding AG is headquartered in Basel, Switzerland, and has established itself as a pioneer in the healthcare industry. The company's commitment to innovation, quality, and patient-centricity has enabled it to make a significant impact on global healthcare.
For more information about Roche Holding AG, please visit their website at https://www.roche.com.